Biomarker based immunoassays have emerged as a cornerstone of modern clinical diagnostics, enabling precise detection and quantification of biological markers associated with diseases. These assays play a pivotal role in early disease identification, therapeutic monitoring, and personalized treatment strategies. In an era where precision medicine is becoming the global standard, biomarker-based...
According to a newly published market research report by 24LifeSciences, global automatic time-resolved fluorescence immunoassay analyzer market was valued at USD 850 million in 2024 and is projected to reach USD 1.65 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025–2032.
Automatic time-resolved fluorescence immunoassay (TRFIA)...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek